» Articles » PMID: 38381868

Post-COVID-19 Syndrome Among Hospitalized COVID-19 Patients: a Cohort Study Assessing Patients 6 and 12 Months After Hospital Discharge

Overview
Specialty Public Health
Date 2024 Feb 21
PMID 38381868
Authors
Affiliations
Soon will be listed here.
Abstract

Post-COVID-19 syndrome involves a variety of symptoms that last more than 12 weeks after COVID diagnosis. This study aimed to analyze post-COVID-19 syndrome among hospitalized COVID-19 patients 6 and 12 months after hospital discharge. This is an ambidirectional cohort study conducted with individuals who were discharged from three main hospitals in the capital of Mato Grosso State, Brazil, between October and December 2021 and January and March 2022. After data collection from medical records, the individuals were interviewed by telephone 6 and 12 months after hospital discharge, when they were asked about the presence of ongoing or new symptoms and when symptom frequency was evaluated according to sociodemographic and economic characteristics hospitalization, and health conditions. Of all 277 medical records evaluated, 259 patients were eligible to participate in the study, 190 patients six months after discharge and 160 patients 12 months after hospital discharge. At six months, 59% were female patients, 40% were aged 60 years or older, and 87.4% reported at least one symptom. At 12 months, 58.7% were female patients, 37.5% were aged 30 to 49 years, and 67.5% reported at least one symptom. Fatigue was the most common symptom 6 and 12 months after hospital discharge (55.3% and 40.6%, respectively), followed by memory problems (36.8%; 20%), and hair loss (26.8%; 11.2%). The prevalence of post-COVID-19 syndrome was higher among patients of older age, lower income, with hypertension, diabetes, and more severe infection during hospitalization. The risk factors for post-COVID-19 syndrome help understand the long-term effects and the importance of monitoring after the acute phase of the disease.

Citing Articles

Post-COVID-19 functional status in socioeconomically vulnerable neighborhoods attended in primary health care in two Brazilian cities: a cross-sectional study.

de Medeiros D, Amorim G, Soares F, Magno L, Rossi T, Torres T BMC Infect Dis. 2025; 25(1):347.

PMID: 40075295 PMC: 11905649. DOI: 10.1186/s12879-025-10729-5.


[Post-COVID-19 conditions in the Brazilian Unified National Health System: exploring the uncertain terrain of identification and coping].

Borges P, Waldman E, Martins C Cad Saude Publica. 2024; 40(7):e00046524.

PMID: 39194137 PMC: 11346609. DOI: 10.1590/0102-311XPT046524.


Long COVID among Brazilian Adults and Elders 12 Months after Hospital Discharge: A Population-Based Cohort Study.

Salci M, Carreira L, Oliveira N, Pereira N, Covre E, Pesce G Healthcare (Basel). 2024; 12(14).

PMID: 39057586 PMC: 11276565. DOI: 10.3390/healthcare12141443.


Long COVID challenges in Brazil: an unfinished agenda for the Brazilian Unified National Health System.

Ramos Jr A Cad Saude Publica. 2024; 40(2):e00008724.

PMID: 38381866 PMC: 10877692. DOI: 10.1590/0102-311XPT008724.

References
1.
Zhang X, Wang F, Shen Y, Zhang X, Cen Y, Wang B . Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China. JAMA Netw Open. 2021; 4(9):e2127403. PMC: 8482055. DOI: 10.1001/jamanetworkopen.2021.27403. View

2.
Talhari C, Criado P, Castro C, Ianhez M, Ramos P, Miot H . Prevalence of and risk factors for post-COVID: Results from a survey of 6,958 patients from Brazil. An Acad Bras Cienc. 2023; 95(1):e20220143. DOI: 10.1590/0001-3765202320220143. View

3.
Al-Aly Z, Xie Y, Bowe B . High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021; 594(7862):259-264. DOI: 10.1038/s41586-021-03553-9. View

4.
Romero-Duarte A, Rivera-Izquierdo M, Guerrero-Fernandez de Alba I, Perez-Contreras M, Fernandez-Martinez N, Ruiz-Montero R . Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021; 19(1):129. PMC: 8134820. DOI: 10.1186/s12916-021-02003-7. View

5.
Ramakrishnan R, Kashour T, Hamid Q, Halwani R, Tleyjeh I . Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front Immunol. 2021; 12:686029. PMC: 8278217. DOI: 10.3389/fimmu.2021.686029. View